6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 18, 2019 at 8:43 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,033
    Likes Received:
    3
    via Despite some ups and downs, Johnson & Johnson's (NYSE: JNJ) pharmaceutical division consistently outperforms its peers in terms of branded drug sales. As a result, pharmaceutical sales are now responsible for a majority of the healthcare conglomerate's total revenue.

    article source